PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development of preventive and therapeutic products derived from organic and nature-identical compounds; synthesized Nature Identical; Sol-Gel Nose-to-Brain delivery platform for Parkinson's disease; develops cannabinoid-based nose-to-brain delivery system for the relief of a various ailments, including pain, inflammation, seizures, and neurological disorders; peptide library synthesis, pharmacological evaluation, alongside pharmacokinetic assessment, and determinations in animal models of pain and inflammation; and non-addictive analgesic peptides for pain management. It also involved in licensing, branding, and marketing nutraceutical and wellness products; Sol-Gel platform; and peptide program. PreveCeutical Medical Inc. is headquartered in West Vancouver, Canada.
Frequently asked questions
What sector does PreveCeutical Medical Inc (PREV) operate in?
PreveCeutical Medical Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is PreveCeutical Medical Inc (PREV) current stock price?
As of the latest data, PreveCeutical Medical Inc stock price is CA$0.02, with a previous close of CA$0.02. PreveCeutical Medical Inc lost -CA$0.01 in the last trading session, representing a -25% loss.
What is PreveCeutical Medical Inc (PREV) current market capitalization?
PreveCeutical Medical Inc market cap is approximately 8.97 million.
Does PreveCeutical Medical Inc (PREV) pay dividends?
No. PreveCeutical Medical Inc does not pay a dividend.
What is PreveCeutical Medical Inc (PREV) beta (volatility) score?
PreveCeutical Medical Inc has a beta of 0.059, indicating lower volatility than the overall market.
